Study of the Risk of Pharyngocutaneous Fistula in a Population of Patients Undergoing Total Laryngectomy and Creation of a Score for Pre-operative Risk Stratification.
1 other identifier
observational
500
1 country
1
Brief Summary
Multicenter retrospective study of a cohort of patients affected by laryngeal carcinoma and subjected to total laryngectomy surgery at the centers participating in the reference period and responding to inclusion criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 6, 2024
CompletedFirst Posted
Study publicly available on registry
March 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMarch 13, 2024
March 1, 2024
1 year
March 6, 2024
March 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Identification of risk factors
The primary objective of the project is the identification of pre-operative risk factors
12 months
Secondary Outcomes (1)
Stratify patients
12 months
Eligibility Criteria
For the present study, data relating to patients who, in a manner, will be analyzed retrospectively consecutive, I meet the following criteria. All patients underwent procedures and/or diagnostic-therapeutic procedures, as well as tests and assessments as required by guidelines and/or conventional clinical management
You may qualify if:
- Patients undergoing LT surgery with direct closure of the pharynx in case of:
- naïve laryngeal neoplasm (cT1-T3 and cT4a without extension to the esophagus or hypopharynx or oropharynx);
- recurrence of laryngeal neoplasm in a patient who has undergone previous surgical treatment (CO2 laser limited within the larynx or OPHL);
- recurrence of laryngeal neoplasm after RT or Ch-RT treatment;
- lack of functionality of the larynx induced by (Ch-)RT treatment;
- Availability of data according to the assessments that will have to be made, including a FU period of 2 months.
You may not qualify if:
- Use of flap, pedicled / free, on-lay / in-lay at the same time as LT surgery. Patients previously subjected to trans-oral surgery of the hypopharynx and/or oropharynx.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
"Regina Elena" National Cancer Institute
Rome, 00144, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raul Pellini, Doctor
IRCCS "Regina Elena" National Cancer Institute
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2024
First Posted
March 13, 2024
Study Start
December 1, 2023
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
March 13, 2024
Record last verified: 2024-03